MANNI, SABRINA
 Distribuzione geografica
Continente #
NA - Nord America 3.494
EU - Europa 553
AS - Asia 484
OC - Oceania 5
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.543
Nazione #
US - Stati Uniti d'America 3.491
CN - Cina 288
IT - Italia 222
SG - Singapore 112
DE - Germania 72
FI - Finlandia 66
SE - Svezia 47
VN - Vietnam 46
GB - Regno Unito 44
FR - Francia 39
UA - Ucraina 32
IN - India 25
NL - Olanda 8
GR - Grecia 7
IE - Irlanda 6
AU - Australia 5
RU - Federazione Russa 4
CA - Canada 3
CL - Cile 3
TW - Taiwan 3
BG - Bulgaria 2
EU - Europa 2
HK - Hong Kong 2
SA - Arabia Saudita 2
TR - Turchia 2
EC - Ecuador 1
HU - Ungheria 1
IQ - Iraq 1
KH - Cambogia 1
MK - Macedonia 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PL - Polonia 1
PT - Portogallo 1
Totale 4.543
Città #
Fairfield 482
Woodbridge 391
Chandler 356
Ann Arbor 277
Ashburn 264
Houston 251
Cambridge 180
Seattle 161
Jacksonville 159
Wilmington 155
Padova 86
Beijing 82
Boardman 77
Singapore 72
Princeton 71
Des Moines 61
San Diego 52
Dong Ket 46
Medford 44
Santa Clara 40
Helsinki 31
Guangzhou 27
Roxbury 25
Nanjing 23
New York 20
Pune 13
Shanghai 12
Hebei 11
Venice 11
Shenyang 10
Milan 9
Changsha 8
Jinan 8
London 8
Dublin 6
Norwalk 6
Borås 5
Rome 5
Verona 5
Amsterdam 4
Bologna 4
Los Angeles 4
Nanchang 4
Bandra 3
Falls Church 3
Frankfurt am Main 3
Hounslow 3
Jiaxing 3
Kunming 3
Munich 3
Phoenix 3
Portland 3
Regensburg 3
Santiago 3
Taizhou 3
Tianjin 3
Zhengzhou 3
Castelfranco Veneto 2
Chiaravalle Centrale 2
Falkenstein 2
Genoa 2
Hanover 2
Hefei 2
Kaohsiung 2
Kilburn 2
Livorno 2
Lucknow 2
Nicotera 2
North York 2
Osimo 2
Paris 2
Redwood City 2
Rockville 2
Sant'elena 2
Sofia 2
Sydney 2
Thiene 2
Acton 1
Ahmedabad 1
Aprilia 1
Baghdad 1
Bitola 1
Budapest 1
Caldiero 1
Chelmsford 1
Chicago 1
Curtarolo 1
Dallas 1
Dundee 1
Fara 1
Forest City 1
Gunzenhausen 1
Haikou 1
Hong Kong 1
Istanbul 1
Jinhua 1
Kraków 1
Lahore 1
Lanzhou 1
Lappeenranta 1
Totale 3.671
Nome #
Prosurvival autophagy is regulated by protein kinase CK1 alpha in multiple myeloma 184
The small GTPase RhoU lays downstream of JAK/STAT signaling and mediates cell migration in multiple myeloma 154
Chromodomain helicase binding protein 8 (Chd8) is a novel A-kinase anchoring protein expressed during rat cardiac development. 147
Protein kinase CK2 regulates AKT, NF-κB and STAT3 activation, stem cell viability and proliferation in acute myeloid leukemia 145
Protein Kinase CK2 Inhibition Down Modulates the NF-κB and STAT3 Survival Pathways, Enhances the Cellular Proteotoxic Stress and Synergistically Boosts the Cytotoxic Effect of Bortezomib on Multiple Myeloma and Mantle Cell Lymphoma Cells 125
Serine-Threonine protein kinases CK1, CK2 and GSK3 in normal and malignant haematopoiesis 119
Targeting CK2-driven non-oncogene addiction in B-cell tumors 117
Lights and Shade of Next-Generation Pi3k Inhibitors in Chronic Lymphocytic Leukemia 114
Severe infections unrelated to neutropenia impact on overall survival in multiple myeloma patients: results of a single centre cohort study 113
Actionable Strategies to Target Multiple Myeloma Plasma Cell Resistance/Resilience to Stress: Insights From “Omics” Research 113
Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity 110
Modulation of ER Stress/Unfolded Protein Response (UPR) Pathways in Multiple Myeloma Cells by Inhibition of Hsp90 and Serine-Threonine Kinase CK2. 110
Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death 107
AKAP-Scaffolding Proteins and Regulation of Cardiac Physiology 106
Analysis of Wnt and Hedgehog Pathways Regulating Protein Kinases CK1 and CK2 in Acute Myeloid Leukemia Cells and Stem Cells: Correlation with the Expression of Wnt and Hedgehog Targets and Biological and Clinical Features 102
Bone marrow stromal cell-fueled multiple myeloma growth and osteoclastogenesis are sustained by protein kinase CK2 102
Inactivation of CK1α in multiple myeloma empowers drug cytotoxicity by affecting AKT and ß-catenin survival signaling pathways 101
Effects of CK2 inhibition on multiple signaling pathways in myeloma cells. 97
Protein kinase CK2 protects multiple myeloma cells from ER stress-induced apoptosis and from the cytotoxic effect of HSP90 inhibition through regulation of the unfolded protein response 97
Old and young actors playing novel roles in the drama of multiple myeloma bone marrow microenvironment dependent drug resistance 90
Modulation of ER Stress/Unfolded Protein Response (UPR) Pathways in Multiple Myeloma Cells by Inhibition of Hsp90 and Serine-Threonine Kinase CK2. 89
Ca2+ signaling in HEK-293 and skeletal muscle cells expressing recombinant ryanodine receptors harbouring malignant hyperthermia and central core disease mutations 87
Ca2+ homeostasis in HEK293 cells expressing the malignant hyperthermia or central core disease mutant ryanodine channels 85
Effects of PMCA and SERCA pumps overexpression on the kinetics of cell Ca2+ signalling 85
CK2 Kinase Inhibitors Display Anti-Myeloma Effects and Antagonize Osteoclast Activity in Models of Multiple Myeloma Bone Marrow Microenvironment 85
Identification of the true hyperdiploid multiple myeloma subset by combining conventional karyotyping and FISH analysis 85
New responsibilities for aged kinases in B-lymphomas 84
A study of the activity of the plasma membrane Na/Ca exchanger in the cellular enviroment 83
NK cells and CD38: Implication for (Immuno)Therapy in Plasma Cell Dyscrasias 83
Phosphorylation of the cAMP-dependent protein kinase (PKA) regulatory subunit modulates PKA-AKAP interaction, substrate phosphorylation, and calcium signaling in cardiac cells 80
Ca2+ signaling in HEK-293 and skeletal muscle cells expressing recombinant ryanodine receptors harbouring malignant hyperthermia and central core disease mutations 76
Treatment Induced Cytotoxic T-Cell Modulation in Multiple Myeloma Patients 74
Novel players in multiple myeloma pathogenesis: role of protein kinases CK2 and GSK3. 69
Protein Kinase CK1α Sustains B-Cell Receptor Signaling in Mantle Cell Lymphoma 69
A case of “double hit” mantle cell lymphoma carrying CCND1 and MYC translocations relapsed/refractory to rituximab bendamustine cytarabine (R-BAC) and ibrutinib 63
A comparative study of the isoforms of plasma membrane Ca2+ pump in intact cells 62
ROLE OF PROTEIN KINASE CK2 IN THE SURVIVAL AND CHEMORESISTANCE OF ACUTE MYELOID LEUKEMIA CELLS. 61
Functional analysis of the malignant hyperthermia or central core disease mutant ryanodine channels in living cells 61
Ca2+ signalling in cells expressing mutated recombinant ryanodine receptors 61
Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties 59
Targeting of HSP70/HSF1 Axis Abrogates In Vitro Ibrutinib-Resistance in Chronic Lymphocytic Leukemia 59
Targeting Protein Kinases in Blood Cancer: Focusing on CK1α and CK2 55
Protein kinase CK2 in hematologic malignancies: reliance on a pivotal cell survival regulator by oncogenic signaling pathways 51
Determinants of Drug Resistance in B-Cell Non-Hodgkin Lymphomas: The Case of Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia 49
Recombinant expression of the plasma membrane Na+/Ca2+ exchanger affects local and global Ca2+ homeostasis in CHO cells 48
SIMULTANEOUS INHIBITION OF PROTEIN KINASE CK2 AND THE PROTEASOME INCREASES MULTIPLE MYELOMA CELL APOPTOSIS AND AFFECTS NF-KB AND STAT 3 SIGNALING PATHWAYS 46
Protein kinase CK2β regulates peripheral B cell development 46
Inhibition of protein kinase CK2 enhances the cytotoxic effect of bortezomib on multiple myeloma cells 43
The long non-coding RNA CDK6-AS1 overexpression impacts on acute myeloid leukemia differentiation and mitochondrial dynamics 43
Recombinant expression of the plasma memembrane Na+/Ca2+ exchanger affects local and global Ca2+ homeostasis in Chinese hamster ovary cells 41
Role of protein kinases CK1 alpha and CK2 in multiple myeloma: Regulation of pivotal survival and stress-managing pathways 41
A bone-based 3D scaffold as an in-vitro model of microenvironment–DLBCL lymphoma cell interaction 38
CK1α/RUNX2 Axis in the Bone Marrow Microenvironment: A Novel Therapeutic Target in Multiple Myeloma 32
Waldenström Macroglobulinemia in Very Elderly (≥75-year-old) Patients: A 33-year-retrospective Cohort Study in an Italian University Hospital 29
Ca2+ homeostasis in a model cell line expressing the mutated ryanodine channels 29
Protein Kinase CK2 represents a new target to boost Ibrutinib and Venetoclax induced cytotoxicity in mantle cell lymphoma 28
CK2β-regulated signaling controls B cell differentiation and function 28
CK2β Regulates Hematopoietic Stem Cell Biology and Erythropoiesis 20
CK2 AND HSP90 SIMULTANEOUS INHIBITION IN MULTIPLE MYELOMA: A POWERFUL TOOL TO KILL MYELOMA CELLS PERTURBING THE UNFOLDING PROTEIN RESPONSE SYSTEM 19
Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapy 11
Impact of the presence and number of chromosomal abnormalities on the clinical outcome in Waldenström Macroglobulinemia: a monocentric experience 8
Totale 4.618
Categoria #
all - tutte 20.250
article - articoli 16.882
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.132


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020549 0 0 0 0 63 54 60 72 63 104 76 57
2020/2021824 57 54 70 90 44 36 43 63 87 123 64 93
2021/2022743 25 68 92 20 66 32 37 90 53 11 80 169
2022/2023689 120 85 14 88 101 102 8 48 77 6 26 14
2023/2024458 16 46 43 33 58 61 41 27 15 41 37 40
2024/2025379 9 86 70 72 142 0 0 0 0 0 0 0
Totale 4.618